Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Phibro Animal Health (PAHC) Cost of Revenue (2016 - 2025)

Historic Cost of Revenue for Phibro Animal Health (PAHC) over the last 14 years, with Q4 2025 value amounting to $241.3 million.

  • Phibro Animal Health's Cost of Revenue rose 1632.81% to $241.3 million in Q4 2025 from the same period last year, while for Dec 2025 it was $997.3 million, marking a year-over-year increase of 3227.52%. This contributed to the annual value of $896.3 million for FY2025, which is 2720.54% up from last year.
  • According to the latest figures from Q4 2025, Phibro Animal Health's Cost of Revenue is $241.3 million, which was up 1632.81% from $244.1 million recorded in Q3 2025.
  • Over the past 5 years, Phibro Animal Health's Cost of Revenue peaked at $268.7 million during Q2 2025, and registered a low of $142.6 million during Q1 2021.
  • Moreover, its 5-year median value for Cost of Revenue was $174.1 million (2022), whereas its average is $185.8 million.
  • As far as peak fluctuations go, Phibro Animal Health's Cost of Revenue decreased by 15.38% in 2023, and later soared by 4444.5% in 2025.
  • Phibro Animal Health's Cost of Revenue (Quarter) stood at $162.0 million in 2021, then rose by 3.22% to $167.3 million in 2022, then increased by 2.43% to $171.3 million in 2023, then grew by 21.05% to $207.4 million in 2024, then increased by 16.33% to $241.3 million in 2025.
  • Its Cost of Revenue was $241.3 million in Q4 2025, compared to $244.1 million in Q3 2025 and $268.7 million in Q2 2025.